Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
Eur J Cancer
; 122: 72-90, 2019 11.
Article
en En
| MEDLINE
| ID: mdl-31634647
Palabras clave
Anticytotoxic T-lymphocyteassociated protein 4; Antiprogrammed cell death 1; Antiprogrammed cell death ligand 1; Aplastic anaemia; Autoimmune haemolytic anaemia; Cytokine release syndrome; Haemophagocytic syndrome; Immune checkpoint inhibitor; Immune thrombocytopenia; Immune-related adverse event; Neutropenia
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Puntos de Control del Ciclo Celular
/
Antineoplásicos Inmunológicos
/
Factores Inmunológicos
/
Inmunoterapia
/
Anticuerpos Monoclonales
/
Neoplasias
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Eur J Cancer
Año:
2019
Tipo del documento:
Article